---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-062908"
form_type: "8-K"
ticker: "VTIX"
cik: "0001606242"
company_name: "Virtuix Holdings Inc."
filed_at: "2026-05-29T21:00:16+00:00"
generated_at: "2026-05-29T21:03:28.376179+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Virtuix wins Air Force SBIR Phase I, expands into neurodivergent therapy, restructures debt with Streeterville

## Summary
- U.S. Air Force AFWERX SBIR Phase I award to develop Virtual Terrain Walk for immersive mission planning using Omni One treadmills.
- Rutgers University deploys Omni One platform for AI-assisted neurodivergent therapy research, including autism therapy.
- Exchanged $3.32M of convertible notes with Streeterville Capital for new $3.47M Pre-Paid Purchase at 6% interest.
- Pre-Paid Purchase allows Streeterville to purchase common shares at fixed price; no additional cash to company.
- Phase II SBIR funding typically exceeds $1M; VTW enables warfighters to physically walk geo-specific virtual terrain.

## SEC filing metadata
- accession: 0001213900-26-062908
- form_type: 8-K
- ticker: VTIX
- cik: 0001606242
- company_name: Virtuix Holdings Inc.
- filed_at: 2026-05-29T21:00:16+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606242/000121390026062908/0001213900-26-062908-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606242/000121390026062908/ea0291960-8k_virtuix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-062908
- JSON: https://secwatch.observer/filing/0001213900-26-062908.json
- Plain text: https://secwatch.observer/filing/0001213900-26-062908.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.